呼吸科非血栓住院患者血浆D-二聚体水平分析
On Admission Plasma Levels of D-Dimer in Patients with Pulmonary Diseases Free from Thromboembolic Clinical Conditions
DOI: 10.12677/ACM.2021.111043, PDF,   
作者: 王志强, 刘珍慧:青岛大学附属医院,呼吸与危重症医学科,山东 青岛;崔 瑷*:首都医科大学附属北京朝阳医院——北京呼吸疾病研究所,北京
关键词: D-二聚体肺结核肺癌胸腔积液诊断D-Dimer Tuberculosis Lung Cancer Pleural Effusion Diagnosis
摘要: 背景与目的:D-二聚体检测对血栓栓塞性疾病的诊断有明显的帮助作用,敏感性高,但特异性差,很多非血栓性疾病也可见血浆D-二聚体水平升高。本研究通过观察和比较不同的呼吸系统疾病患者血浆D-二聚体水平,进一步评价其在呼吸系统疾病中的诊断价值。方法:本研究纳入自2019年4月至2019年6月青岛大学附属医院全部住院患者,排除其中合并有血栓栓塞性疾病患者及诊断不清者,收集相关临床资料,采用酶联免疫吸附试验(ELISA)检测患者住院当天血浆中D-二聚体的水平,按照出院时确定诊断对患者进行分组,评价D-二聚体在呼吸系统各疾病中检测水平的差异。结果:共纳入365例患者,其中静脉血栓栓塞症(Venous Thromboembolism, VTE)患者26例;其他患者339例,包括慢性阻塞性肺疾病,间质性肺病,支气管扩张,支气管哮喘,社区获得性肺炎,肺癌以及肺结核。VTE组中血浆D-二聚体水平(1800.3 ± 1686.8 ng/ml)显著高于非VTE组中血浆D-二聚体水平(1050.3 ± 1425.4 ng/ml) (p = 0.001),但血浆D-二聚体水平在VTE与结核和肺癌无差异。无论是结核、肿瘤,还是社区获得性肺炎,伴有胸腔积液的患者血浆D-二聚体水平比不伴有胸腔积液的患者显著升高。用来鉴别结核性胸腔积液(TPE)和恶性胸腔积液(MPE)的血浆D-二聚体水平曲线下面积为0.796 (95%置信区间:0.571~0.968)。临界值为1720 ng/ml,灵敏度为69.2%,特异性为83.3%。结论:血浆D-二聚体水平升高对于鉴别VTE与其他非血栓性呼吸系统疾病的价值有限,尤其是结核和肿瘤。而血浆D-二聚体水平在TPE明显升高,其水平显著超过MPE,血浆D-二聚体水平可能作为鉴别TPE和MPE的一个辅助指标。
Abstract: Background and Objectives: The use of D-dimer testing improved the diagnostics in pulmonary embolism and venous thrombosis (VTE). The aim of the present study was to evaluate and compare the serum D-dimer levels in patients with various lung diseases and determine whether serum D-dimer could be helpful in predicting the etiology of those pulmonary diseases. Patients and Methods: The study group included 365 consecutive patients. There were 26 with acute VTE, 339 with COPD, interstitial lung diseases (ILDs), bronchiectasis, asthma, community-acquired pneumonia (CAP), lung malignancy and tuberculosis (TB). Plasma D-dimer levels were analyzed by using an ELISA-method on the day of admission. Results: Mean plasma D-dimer concentration was 1800.3 ± 1686.8 ng/ml in VTE and 1050.3 ± 1425.4 ng/ml in the non-VTE group (p = 0.001), especially in lung cancer, CAP, ILDs and TB. There was a significant elevated level of D-dimer in patients with pleural effusion (2085.7 ± 1707.4 ng/ml) compared with each diseases without pleural effusion (1041.1 ± 1230.8 ng/ml) (p < 0.01). The area under curve when plasma D-dimer was used to differentiate TPE from MPE was 0.796 (95% confidence interval: 0.571~0.968). With a cut-off value of 1720 ng/ml, the sensitivity was 69.2% and the specificity was 83.3%. Conclusions: Plasma D-dimer levels are as higher as VTE in many lung diseases including lung cancer, CAP, ILDs and TB, especially in those diseases with pleural effusion. TPE has extremely elevated plasma D-dimer level and it may serve as a differential diagnostic marker for TPE from MPE.
文章引用:王志强, 刘珍慧, 崔瑷. 呼吸科非血栓住院患者血浆D-二聚体水平分析[J]. 临床医学进展, 2021, 11(1): 293-301. https://doi.org/10.12677/ACM.2021.111043

参考文献

[1] Torbicki, A., Perrier, A., Konstantinides, S., Agnelli, G., Galie, N., Pruszczyk, P., et al. (2008) Guidelines on the Diagnosis and Management of Acute Pulmonary Embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). European Heart Journal, 29, 2276-2315.
[2] Dominic, S., Margreet, S., Marianne, S., Bartels, P.C., van derWerf, T.S. and Boersma, W.G. (2012) D-Dimer Levels in Assessing Severity and Clinical Outcome in Patients with Community-Acquired Pneumonia. A Secondary Analysis of a Randomised Clinical Trial. European Journal of Internal Medicine, 23, 436-441. [Google Scholar] [CrossRef] [PubMed]
[3] Shen, Y., Yang, T., Jia, L., Wang, T., Chen, L., Wan, C., et al. (2013) A Potential Role for D-Dimer in the Diagnosis of Tuberculous Pleural Effusion. European Review for Medical and Pharmacological Sciences, 17, 201-205.
[4] Sabit, R., Thomas, P., Shale, D.J., Collins, P. and Linnane, S.J. (2010) The Effects of Hypoxia on Markers of Coagulation and Systemic Inflammation in Patients with COPD. Chest, 138, 47-51. [Google Scholar] [CrossRef] [PubMed]
[5] Kucher, N., Kohler, H.P., Dornhoefer, T., Wallmann, D. and Laemmle, B. (2003) Accuracy of D-Dimer/Fibrinogen Ratio to Predict Pulmonary Embolism: A Prospective Diagnostic Study. Journal of Thrombosis and Haemostasis, 1, 708-713. [Google Scholar] [CrossRef] [PubMed]
[6] Rutschmann, O.T., Cornuz, J., Poletti, P.-A., Bridevaux, P.-O., Hugli, O.W., Qanadli, S.D., et al. (2007) Should Pulmonary Embolism Be Suspected in Exacerbation of Chronic Obstructive Pulmonary Disease? Thorax, 62, 121-125. [Google Scholar] [CrossRef] [PubMed]
[7] Fogarty, A.W., Lewis, S.A., McKeever, T.M., Lowe, G.D.O., Clark, L. and Britton, J. (2010) The Association between Blood Coagulation Activity and Lung Function: A Population-Based Study. PLoS ONE, 5, e15014. [Google Scholar] [CrossRef] [PubMed]
[8] Sabit, R., Thomas, P., Shale, D.J., Collins, P. and Linnane, S.J. (2010) The Effects of Hypoxia on Markers of Coagulation and Systemic Inflammation in Patients with COPD. Chest, 138, 47-51. [Google Scholar] [CrossRef] [PubMed]
[9] Wang, Y.Q., Sun, N.N., Chen, Z.Z. and Tong, L. (2014) Optimal Time to Use Low Molecular Weight Heparin on Prethrombotic State of Rat Chronic Obstructive Pulmonary Disease Model. Chinese Medical Journal, 127, 518-521.
[10] Silva, D.R., Coelho, A.C., Gazzana, M.B., et al. (2012) D-Dimer Levels in Stable COPD Patients: A Case-Control Study. COPD, 9, 426-431. [Google Scholar] [CrossRef] [PubMed]
[11] Bargagli, E., Madioni, C., Bianchi, N., Refini, R.M., Cappelli, R. and Rottoli, P. (2014) Serum Analysis of Coagulation Factors in IPF and NSIP. Inflammation, 37, 10-16. [Google Scholar] [CrossRef] [PubMed]
[12] Andersen, C.U., Mellemkjar, S., Nielsen-Kudsk, J.E., Bendstrup, E., Simonsen, U. and Hilberg, O. (2012) Diagnostic and Prognostic Role of Biomarkers for Pulmonary Hypertension in Interstitial Lung Disease. Respiratory Medicine, 106, 1749-1755. [Google Scholar] [CrossRef] [PubMed]
[13] Noth, I., Anstrom, K.J., Calvert, S.B., de Andrade, J., Flaherty, K.R., Glazer, C., et al. (2012) A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine, 186, 88-95. [Google Scholar] [CrossRef
[14] Snijders, D., Schoorl, M., Schoorl, M., Bartels, P.C., van derWerf, T.S. and Boersma, W.G. (2012) D-Dimer Levels in Assessing Severity and Clinical Outcome in Patients with Community-Acquired Pneumonia. A Secondary Analysis of a Randomized Clinical Trial. European Journal of Internal Medicine, 23, 436-441. [Google Scholar] [CrossRef] [PubMed]
[15] Zhou, Y.-X., Yang, Z.-M., Feng, J., Shan, Y.-J., Wang, W.-L. and Mei, Y.-Q. (2013) High Plasma D-Dimer Level Is Associated with Decreased Survival in Patients with Lung Cancer: A Meta-Analysis. Tumor Biology, 34, 3701-3704. [Google Scholar] [CrossRef] [PubMed]
[16] Shen, Y., Yang, T., Jia, L., Wang, T., Chen, L., Wan, C., et al. (2013) A Potential Role for D-Dimer in the Diagnosis of Tuberculous Pleural Effusion. European Review for Medical and Pharmacological Sciences, 17, 201-205.